أعرض في EDS

EE10 Cost-Effectiveness of Pembrolizumab Plus Chemotherapies for First-Line Treatment in Locally Advanced Unresectable or Metastatic Triple Negative Breast Cancer (MTNBC) in France

التفاصيل البيبلوغرافية
العنوان:	EE10 Cost-Effectiveness of Pembrolizumab Plus Chemotherapies for First-Line Treatment in Locally Advanced Unresectable or Metastatic Triple Negative Breast Cancer (MTNBC) in France
المؤلفون:	O Tredan, L Bensimon, M Apert, B Tehard, M Carita, A Khandelwal, J Gandhi, A Haiderali, M Huang, P Levy
المصدر:	Value in Health. 25:S54-S55
بيانات النشر:	Elsevier BV, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	Health Policy, Public Health, Environmental and Occupational Health
تدمد:	1098-3015
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::1caff77361a27044748be69010add989 https://doi.org/10.1016/j.jval.2022.09.264
حقوق:	CLOSED
رقم الأكسشن:	edsair.doi...........1caff77361a27044748be69010add989
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	10983015